U.S. NIH starts trial for Shionogi’s COVID-19 pill
Ensitrelvir is an oral antiviral agent taken once daily for five days to suppress replication of the virus
Ensitrelvir is an oral antiviral agent taken once daily for five days to suppress replication of the virus